(75) reported that the administration of specific small interfering RNAs targeting VEGF and Placenta Growth Factor (PIGF) via nanoparticles to M2-polarized TAMs and BC cells as an immunotherapeutic approach markedly inhibits BC growth and pulmonary metastasis. This evidence concerns the gene PIGF and breast cancer.